Low-dose chemotherapy remodels hepatic immune landscape and potentiates anti-tumor response to immune checkpoint blockade in cholangiocarcinoma.

Journal:

Hepatology

Published:

2026-03-05

DOI:

10.1097/hep.0000000000001735

Affiliations:

10

Authors:

20

Go to article

Institutions	Authors	Share
The Third Affiliated Hospital, SYSU, China	13.000000 13.000000	0.65
Eastern Hepatobiliary Surgery Hospital (EHBH), SMMU, China	2.000000	0.10
State Key Laboratory of Oncology in South China, SYSUCC, China	1.000000	0.05
The Sixth Affiliated Hospital, SYSU, China	1.000000	0.05
Guangdong Academy of Medical Sciences (Guangdong Provincial People’s Hospital), China	1.000000	0.05
Sun Yat-sen University (SYSU), China	1.000000	0.05
Second Affiliated Hospital, SCUT, China	1.000000	0.05

Interested in Oncology and Carcinogenesis?